[HIGHLIGHTS] German and U.S. pharmaceutical companies announced that their joint-developed mRNA vaccine phase III trial has an effective rate of 90% 2020-11-09T23:47:16.541Z Read the full translated version in English Read the full version from chinanews May on the same topic in other locals All news stories on 2020-11-09